Mulling Bernanke's ...
Consumer Goods: Consumer Non-Durables
DS Healthcare Group Inc (DSKX: NASDAQ)
$2.15 0.05 | 2.38%
06/19/13 - 03:59 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 12.17M | 9.67M | 5.45M | 3.52M |
| Cost of Sales | 6.46M | 4.55M | 1.76M | 1.07M |
| Gross Operating Profit | 5.71M | 5.12M | 3.69M | 2.45M |
| Selling, General, and Administrative Expenses | 8.09M | 5.91M | 3.75M | 2.85M |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income before D & A (EBITDA) | -2.37M | -792.85K | -62.80K | -399.58K |
| Depreciation & Amortization | 293.02K | 200.72K | 118.18K | 35.74K |
| Interest Income | 2.17K | 454.00 | 0.00 | 72.00 |
| Other Income - Net | -909.51K | 12.22K | 31.17K | 121.08K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -3.57M | -980.89K | -149.81K | -314.17K |
| Interest Expense | 50.30K | 0.00 | 0.00 | 2.05K |
| Pre-Tax Income | -3.62M | -980.89K | -149.81K | -316.22K |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | -16.37K | -2.29K | -12.74K | 0.00 |
| Net Income From Continuing Operations | -3.62M | -978.60K | -137.07K | -316.22K |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -3.62M | -978.60K | -137.07K | -316.22K |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -3.61M | -978.60K | -137.07K | -316.22K |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-3.62M | -978.60K | -137.07K | -316.22K |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -3.62M | -978.60K | -137.07K | -316.22K |
| Basic EPS from Continuing Ops. | -0.33 | -0.10 | -0.02 | -0.04 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.33 | -0.10 | -0.02 | -0.04 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.33 | -0.10 | -0.02 | -0.04 |
| Basic Normalized Net Income/Share | -0.33 | -0.10 | -0.02 | -0.04 |
| EPS fr Continuing Ops. | -0.33 | -0.10 | -0.02 | -0.04 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.33 | -0.10 | -0.02 | -0.04 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.33 | -0.10 | -0.02 | -0.04 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.33 | -0.10 | -0.02 | -0.04 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with DSKX
- Portfolio NameUser Type
Latest DSKX Headlines from TheStreet
- DS Healthcare Launches Revita.LT High-Performance Hair-Stimulating Shampoo For Blond And Light Colors 05.28.13 | 12:05 pm
- DS Healthcare Group Reports First Quarter 2013 Revenues Up 100% To $3,965,000 05.16.13 | 02:05 pm
- DS Healthcare Launches Spectral.DNC-N, First-of-its-kind Product To Help Prevent Thinning Hair 05.02.13 | 08:05 am
- DS Healthcare Group Announces Financial Results For Year Ended December 31, 2012 04.25.13 | 05:04 pm
- DS Healthcare Launches In Brazil The World's Second Largest Cosmetics Market 02.06.13 | 08:02 am
- DS Healthcare Group To Begin Trading On NASDAQ Capital Markets 12.11.12 | 12:12 pm
- Divine Skin Reports Q2 Revenues Grow 50% To $3.5 Million 08.14.12 | 01:08 pm
Press Releases for DSKX
- Divine Skin Adds Keith Markey, Ph.D. To Its Board Of Directors - PR Newswire 07.09.12 | 06:07 am
- Divine Skin To Begin Manufacturing Its OTC Pain Reliever - PR Newswire 06.26.12 | 06:06 am
- Divine Skin Projects Revenues To Reach $15M In 2012 - PR Newswire 05.16.12 | 09:05 am
- Divine Skin Secures $1.5 Million Line Of Credit With MidCap Business Credit LLC - PR Newswire 04.11.12 | 08:04 am
- Divine Skin Signs Letter Of Intent To Acquire Its Mexican Distributor - PR Newswire 03.22.12 | 08:03 am
- Divine Skin's NutraOrigin Brand Sells To United Natural Foods - PR Newswire 02.28.12 | 08:02 am
- Divine Skin Q4 Tops $3 Million; 2011 Revenue Reaches $9.6 Million, Up 78% Over 2010 - PR Newswire 02.09.12 | 08:02 am
- Another Successful Year At Divine Skin - PR Newswire 12.21.11 | 11:12 am
- Divine Skin's NutraOrigin Supplements Tested In Four Whole Foods Markets; Full Rollout Planned For 2012 - PR Newswire 11.30.11 | 08:11 am
- Divine Skin Posts Q3 Revenue Of $2.1 Million, Up 35% From 2010 - PR Newswire 11.15.11 | 08:11 am
Partner Headlines for DSKX
